Bellevue Life Sciences Acquisit (BLACU) Net Income

Annual Net Income

$403.80 K
+$439.20 K+1240.68%

31 December 2023

BLACU Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

-$231.00 K
-$133.70 K-137.41%

30 September 2024

BLACU Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

-$474.90 K
-$309.20 K-186.60%

30 September 2024

BLACU TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BLACU Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year--168.0%-217.6%
3 y3 years+10000.0%-10000.0%-10000.0%
5 y5 years+101.2%--

BLACU Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+1240.7%-176.6%at low-199.8%at low
5 y5 yearsat high+100.9%-176.6%at low-199.8%at low
alltimeall timeat high+100.9%-176.6%at low-199.8%at low

Bellevue Life Sciences Acquisit Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
-$231.00 K(+137.4%)
-$474.90 K(+186.6%)
June 2024
-
-$97.30 K(+61.1%)
-$165.70 K(-171.1%)
Mar 2024
-
-$60.40 K(-29.9%)
$233.10 K(-42.3%)
Dec 2023
$403.80 K(-1240.7%)
-$86.20 K(-210.2%)
$403.80 K(-15.1%)
Sept 2023
-
$78.20 K(-74.1%)
$475.70 K(+26.0%)
June 2023
-
$301.50 K(+173.3%)
$377.50 K(+403.3%)
Mar 2023
-
$110.30 K(-871.3%)
$75.00 K(-311.9%)
Dec 2022
-$35.40 K
-
-
Dec 2022
-
-$14.30 K(-28.5%)
-$35.40 K(+65.4%)
Sept 2022
-
-$20.00 K(+1900.0%)
-$21.40 K(+1326.7%)
June 2022
-
-$1000.00(+900.0%)
-$1500.00(-53.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$100.00(-66.7%)
-$3200.00(+3.2%)
Dec 2021
-$3300.00(-100.0%)
-$300.00(+200.0%)
-$3100.00(+10.7%)
Sept 2021
-
-$100.00(-96.3%)
-$2800.00(+3.7%)
June 2021
-
-$2700.00
-$2700.00
Dec 2020
-$46.91 M(+44.2%)
-
-
Dec 2019
-$32.53 M(+17.0%)
-
-
Dec 2018
-$27.80 M(-26.9%)
-
-
Dec 2017
-$38.06 M(-2.8%)
-
-
Dec 2016
-$39.16 M(+58.3%)
-
-
Dec 2015
-$24.73 M(+47.6%)
-
-
Dec 2014
-$16.75 M
-
-

FAQ

  • What is Bellevue Life Sciences Acquisit annual net profit?
  • What is the all time high annual net income for Bellevue Life Sciences Acquisit?
  • What is Bellevue Life Sciences Acquisit quarterly net profit?
  • What is the all time high quarterly net income for Bellevue Life Sciences Acquisit?
  • What is Bellevue Life Sciences Acquisit quarterly net income year-on-year change?
  • What is Bellevue Life Sciences Acquisit TTM net profit?
  • What is the all time high TTM net income for Bellevue Life Sciences Acquisit?
  • What is Bellevue Life Sciences Acquisit TTM net income year-on-year change?

What is Bellevue Life Sciences Acquisit annual net profit?

The current annual net income of BLACU is $403.80 K

What is the all time high annual net income for Bellevue Life Sciences Acquisit?

Bellevue Life Sciences Acquisit all-time high annual net profit is $403.80 K

What is Bellevue Life Sciences Acquisit quarterly net profit?

The current quarterly net income of BLACU is -$231.00 K

What is the all time high quarterly net income for Bellevue Life Sciences Acquisit?

Bellevue Life Sciences Acquisit all-time high quarterly net profit is $301.50 K

What is Bellevue Life Sciences Acquisit quarterly net income year-on-year change?

Over the past year, BLACU quarterly net profit has changed by -$144.80 K (-167.98%)

What is Bellevue Life Sciences Acquisit TTM net profit?

The current TTM net income of BLACU is -$474.90 K

What is the all time high TTM net income for Bellevue Life Sciences Acquisit?

Bellevue Life Sciences Acquisit all-time high TTM net profit is $475.70 K

What is Bellevue Life Sciences Acquisit TTM net income year-on-year change?

Over the past year, BLACU TTM net profit has changed by -$878.70 K (-217.61%)